Bottom line
Is BSGSX a good fund? The bottom line
BSGSX is the Investor Class share class of Baird Small/Mid Cap Growth Fund, an actively managed mid-cap mutual fund from Baird.
Annual fees run 1.1% — about $110 a year on every $10,000 invested, more expensive than 69% of mid-cap funds we track.
It returned −9.0% over one year, −1.4% a year over five years (as of Dec 31, 2025, per its prospectus).
With $77.5 million in net assets and 58 holdings, its largest position is First American Government Obli (3.6%) and the top 10 make up 28.2% of the portfolio.
What to watch
- 5-year return in the bottom quarter of its category
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What BSGSX invests in
The investment objective of the Baird Small/Mid Cap Growth Fund (the Fund) is to provide long-term growth of capital.
The Fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in the equity securities of U.S. and foreign small- and mid-capitalization companies, principally common stocks and American Depositary Receipts (ADRs) that are traded on major U.S. exchanges. Although the Fund principally invests in U.S. companies, the Fund may invest up to 15% of its total assets in equity securities (consisting of common stocks, ordinary shares and ADRs) of foreign companies. The Fund defines small- and mid-capitalization companies as those companies with a market capitalization within the range of companies in the Russell 2500 Growth Index at the time of investment. When analyzing equity securities to be purchased by the Fund, the Advisor emphasizes a companys growth prospects. The Funds investments are selected using a variety of both quantitative techniques and…
From the fund's prospectus (filed May 4, 2026).
BSGSX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| BSGSX | −9.0% | −1.4% | — |
| Mid-Cap median | +7.9% | +8.1% | +9.9% |
Source: Fund prospectus, as of Dec 31, 2025
What BSGSX costs
On a $10,000 investment, BSGSX's 1.1% expense ratio costs about $110 a year. The prospectus estimates $1,425 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.
BSGSX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | First American Government Obli | 3.61% |
| 2 | Neurocrine Biosciences Inc NBIX | 3.26% |
| 3 | Curtiss-Wright Corp CW | 3.24% |
| 4 | Twist Bioscience Corp TWST | 3.05% |
| 5 | Victoria's Secret & Co VSXY | 2.73% |
| 6 | Dutch Bros Inc BROS | 2.66% |
| 7 | FTAI Aviation Ltd FTAI | 2.63% |
| 8 | Twilio Inc TWLO | 2.51% |
| 9 | UL Solutions Inc ULS | 2.28% |
| 10 | Woodward Inc WWD | 2.24% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 28.2% of the fund. See all top 25 holdings and asset mix →